ArticleCancer immunology, immunotherapy : CII2022

Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer.

Harsimar B Kaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.